Fingerprint
Dive into the research topics of 'Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
OPERA I and OPERA II Clinical Investigators, Andrejs Millers
Research output: Contribution to journal › Article › peer-review
1406
Citations
(Scopus)